Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
162 hedge funds and large institutions have $1.34B invested in Portola Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 39 increasing their positions, 49 reducing their positions, and 79 closing their positions.
1,100% more funds holding in top 10
Funds holding in top 10: 1 → 12 (+11)
140% more capital invested
Capital invested by funds: $557M → $1.34B (+$781M)
13% less funds holding
Funds holding: 187 → 162 (-25)
20% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 49
29% less first-time investments, than exits
New positions opened: 56 | Existing positions closed: 79
65% less call options, than puts
Call options by funds: $9M | Put options by funds: $25.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$55.9M |
| 2 |
OP
Omni Partners
London,
United Kingdom
|
+$44.7M |
| 3 |
WIC
Water Island Capital
New York
|
+$32.7M |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$32.3M |
| 5 |
Goldman Sachs
New York
|
+$32.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$141M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$71.3M |
| 3 |
Temasek Holdings
Singapore
|
-$34.2M |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$24.9M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$13.9M |
PTLA Hedge Fund Activity: Q2 2020 in Review
162 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q2 2020, worth a combined $1.34B — up 140% from $557M a quarter earlier.
Sellers outnumbered buyers: 79 funds closed out of PTLA and 56 opened new positions — a net loss of 23 holders — while 49 trimmed existing stakes and 39 added.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $55.9M. The largest seller was Wellington Management Group, cutting an estimated $141M.
- 162 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q2 2020, down from 187 in Q1 2020.
- Funds reported $1.34B of Portola Pharmaceuticals, Inc. stock for Q2 2020, up 140% quarter-over-quarter.
- 56 funds opened new Portola Pharmaceuticals, Inc. positions in Q2 2020 and 79 closed out, a net change of -23 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q2 2020 was Magnetar Financial, an estimated $55.9M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q2 2020 was Wellington Management Group, an estimated $141M sold.
Based on aggregated 13F filings for Q2 2020.